We’re looking at debt-to-equity ratios, which measure how aggressively a company finances its growth using debt. It’s an important metric, especially during rough economic patches, because highly leveraged companies run the risk of not generating enough growth to outweigh the cost of the debt – which could lead to bankruptcy.
Here’s a look at the 5 highest debt ratios among the pure-play medical device companies on our Big 100 list:
Want more data? Download the 2012 MassDevice Big 100
And here’s a look at the 5 highest leverage scores among the pure-play medical device companies on our Big 100 list:
You can drill down further into the data with the MassDevice Big 100 Deluxe for just $79.99, which includes in-depth interviews with some of med-tech’s most interesting CEOs.